Deficient	O
cMyBP	B:C1527800
-	I:C1527800
C	I:C1527800
protein	B:C1171362
expression	I:C1171362
during	O
cardiomyocyte	B:C1817118
differentiation	I:C1817118
underlies	O
human	B:C0086418
hypertrophic	B:C0007194
cardiomyopathy	I:C0007194
cellular	B:C0178539
phenotypes	O
in	O
disease	B:C0012634
specific	O
human	B:C1171346
ES	I:C1171346
cell	I:C1171346
derived	O
cardiomyocytes	B:C0225828
.	O

Mutations	B:C0596611
of	O
cardiac	B:C0018787
sarcomere	B:C0036225
genes	B:C0017337
have	O
been	O
identified	O
to	O
cause	O
HCM	B:C0007194
,	O
but	O
the	O
molecular	B:C1148560
mechanisms	I:C1148560
that	O
lead	O
to	O
cardiomyocyte	B:C4227331
hypertrophy	I:C4227331
and	O
risk	B:C4014370
for	I:C4014370
sudden	I:C4014370
death	I:C4014370
are	O
uncertain	B:C0087130
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
HCM	B:C0007194
disease	B:C1515006
mechanisms	I:C1515006
at	O
play	O
during	O
cardiac	B:C2247990
differentiation	I:C2247990
of	O
human	B:C0086418
HCM	B:C0007194
specific	O
pluripotent	B:C0872076
stem	I:C0872076
cells	I:C0872076
.	O

We	O
generated	O
a	O
human	O
embryonic	O
stem	O
cell	O
(	O
hESC	O
)	O
line	O
carrying	O
a	O
naturally	O
occurring	O
mutation	B:C0596611
of	O
MYPBC3	B:C1417523
(	O
c.2905	B:C0596611
+1	I:C0596611
G	I:C0596611
>	I:C0596611
A	I:C0596611
)	O
to	O
study	O
HCM	B:C0007194
pathogenesis	B:C0699748
during	O
cardiac	B:C2247990
differentiation	I:C2247990
.	O

HCM	B:C0007194
-	O
specific	O
human	B:C1171346
embryonic	I:C1171346
stem	I:C1171346
cell	I:C1171346
-	O
derived	O
cardiomyocytes	B:C0225828
(	O
hESC	B:C0225828
-	I:C0225828
CMs	I:C0225828
)	O
displayed	O
hallmark	O
aspects	O
of	O
HCM	B:C0007194
including	O
sarcomere	B:C0036225
disarray	B:C0302142
,	O
hypertrophy	B:C0020564
and	O
impaired	O
calcium	B:C0007613
impulse	I:C0007613
propagation	I:C0007613
.	O

HCM	B:C0007194
hESC	B:C0225828
-	I:C0225828
CMs	I:C0225828
presented	O
a	O
transient	O
haploinsufficiency	B:C2936267
of	O
cMyBP	B:C1527800
-	I:C1527800
C	I:C1527800
during	O
cardiomyocyte	B:C1817118
differentiation	I:C1817118
,	O
but	O
by	O
day	O
30	O
post	O
-	O
differentiation	B:C1817118
cMyBP	B:C1527800
-	I:C1527800
C	I:C1527800
levels	O
were	O
similar	O
to	O
control	O
hESC	B:C0225828
-	I:C0225828
CMs	I:C0225828
.	O

Gene	B:C1517499
transfer	I:C1517499
of	O
full	O
-	O
length	O
MYBPC3	B:C1417523
during	O
differentiation	B:C1817118
prevented	O
hypertrophy	B:C0020564
,	O
sarcomere	B:C0036225
disarray	B:C0302142
and	O
improved	B:C0184511
calcium	B:C0007613
impulse	I:C0007613
propagation	I:C0007613
in	O
HCM	B:C0007194
hESC	B:C0225828
-	I:C0225828
CMs	I:C0225828
.	O

These	O
findings	B:C0243095
point	O
to	O
the	O
critical	O
role	O
of	O
MYBPC3	B:C1417523
during	O
sarcomere	B:C0036225
assembly	O
in	O
cardiac	B:C1817118
myocyte	I:C1817118
differentiation	I:C1817118
and	O
suggest	O
developmental	O
influences	O
of	O
MYBPC3	B:C1417523
truncating	O
mutations	B:C0596611
on	O
the	O
mature	O
hypertrophic	O
phenotype	O
.	O

